UnknownEarly Phase 1NCT04184453
Clinical Curative Effect Evaluation Study of Treatment of Oral Deferiprone Tablets in Aceruloplasminaemia Patients
Studying Aceruloplasminemia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- First Affiliated Hospital of Fujian Medical University
- Principal Investigator
- Wanjin ChenDepartment of Neurology , First Affiliated Hospital Fujian Medical University
- Intervention
- Deferiprone treated(drug)
- Enrollment
- 5 enrolled
- Eligibility
- 18-80 years · All sexes
- Timeline
- 2019 – 2022
Study locations (1)
- Department of Neurology , First Affiliated Hospital Fujian Medical University, Fuzhou, Fujian, China
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT04184453 on ClinicalTrials.govOther trials for Aceruloplasminemia
Additional recruiting or active studies for the same condition.